Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_assertion type Assertion NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_head.
- NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_assertion description "[For idiopathic VTE, in addition to the factor V (Leiden) mutation (odds ratio [OR], 5.13; 95% confidence interval [CI], 3.24 to 8.14; P<0.0001; false discovery rate [FDR], P<0.0001), an N291S lipoprotein lipase gene polymorphism (OR, 3.09; 95% CI, 1.56 to 6.09; P=0.001; FDR, P=0.036) and a Q27E beta2-adrenergic receptor gene polymorphism (OR, 1.40; 95% CI, 1.09 to 1.79; P=0.006; FDR, P=0.036) were found to be significantly associated with increased risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_provenance.
- NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_assertion evidence source_evidence_literature NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_provenance.
- NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_assertion SIO_000772 16651467 NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_provenance.
- NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_assertion wasDerivedFrom befree-20150227 NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_provenance.
- NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_assertion wasGeneratedBy ECO_0000203 NP539518.RACNX8qf_03S9CPJ2nWltJum6vQMg_kzrcKi0CczcDYdM130_provenance.